Glatiramer acetate: long-term safety and efficacy in relapsing-remitting multiple sclerosis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glatiramer acetate: long-term safety and efficacy in relapsing-remitting multiple sclerosis
Authors
Keywords
-
Journal
Expert Review of Neurotherapeutics
Volume 15, Issue 6, Pages 575-586
Publisher
Informa UK Limited
Online
2015-04-30
DOI
10.1586/14737175.2015.1040768
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Retrospective US database analysis of persistence with glatiramer acetate vs. available disease-modifying therapies for multiple sclerosis: 2001–2010
- (2014) MerriKay Oleen-Burkey et al. BMC Neurology
- Immunomodulation neuroprotection and remyelination – The fundamental therapeutic effects of glatiramer acetate: A critical review
- (2014) Rina Aharoni JOURNAL OF AUTOIMMUNITY
- A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial
- (2014) Tjalf Ziemssen et al. JOURNAL OF NEUROLOGY
- Effect of glatiramer acetate three-times weekly on the evolution of new, active multiple sclerosis lesions into T1-hypointense “black holes”: a post hoc magnetic resonance imaging analysis
- (2014) Robert Zivadinov et al. JOURNAL OF NEUROLOGY
- Long-term safety and effectiveness of natalizumab redosing and treatment in the STRATA MS Study
- (2014) P. O'Connor et al. NEUROLOGY
- Comparative pharmacogenetics of multiple sclerosis: IFN-β versus glatiramer acetate
- (2014) Olga G Kulakova et al. PHARMACOGENOMICS
- Comparing the Biological Impact of Glatiramer Acetate with the Biological Impact of a Generic
- (2014) Fadi Towfic et al. PLoS One
- The Effect of Glatiramer Acetate Therapy on Functional Properties of B Cells From Patients With Relapsing-Remitting Multiple Sclerosis
- (2014) Sara J. Ireland et al. JAMA Neurology
- Cost-effectiveness of glatiramer acetate and interferon beta-1a for relapsing-remitting multiple sclerosis, based on the CombiRx study
- (2014) Josep Darbà et al. JOURNAL OF MEDICAL ECONOMICS
- How to Regulate Nonbiological Complex Drugs (NBCD) and Their Follow-on Versions: Points to Consider
- (2013) Huub Schellekens et al. AAPS Journal
- Three times weekly glatiramer acetate in relapsing-remitting multiple sclerosis
- (2013) Omar Khan et al. ANNALS OF NEUROLOGY
- Randomized study combining interferon and glatiramer acetate in multiple sclerosis
- (2013) Fred D. Lublin et al. ANNALS OF NEUROLOGY
- Pharmacogenomics of interferon beta and glatiramer acetate response: A review of the literature
- (2013) Sunil Mahurkar et al. AUTOIMMUNITY REVIEWS
- Glatiramer Acetate: A Review of Its Use in Patients with Relapsing-Remitting Multiple Sclerosis and in Delaying the Onset of Clinically Definite Multiple Sclerosis
- (2013) Lesley J. Scott CNS DRUGS
- Long-Term Effects of Exposure to Disease-Modifying Drugs in the Offspring of Mothers with Multiple Sclerosis: A Retrospective Chart Review
- (2013) Yara D. Fragoso et al. CNS DRUGS
- Gene expression analysis reveals functional pathways of glatiramer acetate activation
- (2013) Shlomo Bakshi et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Neuroprotection with glatiramer acetate: evidence from the PreCISe trial
- (2013) Douglas L. Arnold et al. JOURNAL OF NEUROLOGY
- HLA DR and DQ alleles and haplotypes associated with clinical response to glatiramer acetate in multiple sclerosis
- (2013) Suhayl Dhib-Jalbut et al. Multiple Sclerosis and Related Disorders
- The mechanism of action of glatiramer acetate in multiple sclerosis and beyond
- (2012) Rina Aharoni AUTOIMMUNITY REVIEWS
- Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study
- (2012) Marta Giannini et al. BMC Neurology
- Cortical lesions in multiple sclerosis: inflammation versus neurodegeneration
- (2012) H. Lassmann BRAIN
- The effects of long-term exposure to disease-modifying drugs during pregnancy in multiple sclerosis
- (2012) Yara Dadalti Fragoso et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Benefit–Risk Analysis of Glatiramer Acetate for Relapsing-Remitting and Clinically Isolated Syndrome Multiple Sclerosis
- (2012) Nawab Qizilbash et al. CLINICAL THERAPEUTICS
- Glatiramer acetate for treatment of relapsing–remitting multiple sclerosis
- (2012) Kenneth P Johnson Expert Review of Neurotherapeutics
- Multiple sclerosis and pregnancy: therapeutic considerations
- (2012) Maria K. Houtchens et al. JOURNAL OF NEUROLOGY
- Effects of early treatment with glatiramer acetate in patients with clinically isolated syndrome
- (2012) Giancarlo Comi et al. Multiple Sclerosis Journal
- Disease-modifying drugs for multiple sclerosis in pregnancy: A systematic review
- (2012) E. Lu et al. NEUROLOGY
- Disease-Modifying Therapy of Pediatric Multiple Sclerosis
- (2012) Tanuja Chitnis Neurotherapeutics
- Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
- (2012) Robert J. Fox et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multiple sclerosis and pregnancy: experience from a nationwide database in Germany
- (2012) Kerstin Hellwig et al. Therapeutic Advances in Neurological Disorders
- Glatiramer Acetate in the Treatment of Multiple Sclerosis
- (2011) Patrice H. Lalive et al. CNS DRUGS
- Distinct pathological patterns in relapsing–remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate
- (2011) Rina Aharoni et al. JOURNAL OF AUTOIMMUNITY
- Recent insights into the mechanism of action of glatiramer acetate
- (2011) Mrinalini Kala et al. JOURNAL OF NEUROIMMUNOLOGY
- Interferon -1b and glatiramer acetate effects on permanent black hole evolution
- (2011) M. Filippi et al. NEUROLOGY
- Comparative Long-Term Preclinical Safety Evaluation of Two Glatiramoid Compounds (Glatiramer Acetate, Copaxone®, and TV-5010, Protiramer) in Rats and Monkeys
- (2011) Yuval Ramot et al. TOXICOLOGIC PATHOLOGY
- Efficacy, safety, and cost-effectiveness of glatiramer acetate in the treatment of relapsing–remitting multiple sclerosis
- (2011) Aaron Boster et al. Therapeutic Advances in Neurological Disorders
- Phase III dose-comparison study of glatiramer acetate for multiple sclerosis
- (2010) Giancarlo Comi et al. ANNALS OF NEUROLOGY
- Multiple Sclerosis Therapies in Pediatric Patients With Refractory Multiple Sclerosis
- (2010) E. Ann Yeh et al. ARCHIVES OF NEUROLOGY
- Glatiramer acetate-reactive T lymphocytes regulate oligodendrocyte progenitor cell number in vitro: Role of IGF-2
- (2010) Y. Zhang et al. JOURNAL OF NEUROIMMUNOLOGY
- Population structure and HLA DRB1*1501 in the response of subjects with multiple sclerosis to first-line treatments
- (2010) Robert Gross et al. JOURNAL OF NEUROIMMUNOLOGY
- Glatiramer acetate exposure in pregnancy: preliminary safety and birth outcomes
- (2010) Heidi J. Salminen et al. JOURNAL OF NEUROLOGY
- Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate
- (2010) C. Ford et al. Multiple Sclerosis Journal
- Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
- (2010) Jeffrey A. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risks vs benefits of glatiramer acetate: a changing perspective as new therapies emerge for multiple sclerosis
- (2010) Kenneth Johnson Therapeutics and Clinical Risk Management
- Glatiramer acetate and interferon beta-1b: a study of outcomes among patients with multiple sclerosis
- (2009) Jane Castelli-Haley et al. ADVANCES IN THERAPY
- The relation between inflammation and neurodegeneration in multiple sclerosis brains
- (2009) Josa M. Frischer et al. BRAIN
- Linkage between immunomodulation, neuroprotection and neurogenesis
- (2009) R. Aharoni et al. DRUG NEWS & PERSPECTIVES
- The glatiramoid class of immunomodulator drugs
- (2009) Haim Varkony et al. EXPERT OPINION ON PHARMACOTHERAPY
- Neuroprotection and neurogeneration in MS and its animal model EAE effected by glatiramer acetate
- (2009) Ruth Arnon et al. JOURNAL OF NEURAL TRANSMISSION
- Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial
- (2009) G Comi et al. LANCET
- 250 μg or 500 μg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study
- (2009) Paul O'Connor et al. LANCET NEUROLOGY
- Multiple sclerosis, immunomodulators, and pregnancy outcome: a prospective observational study
- (2009) C Weber-Schoendorfer et al. Multiple Sclerosis Journal
- Efficacy of treatment of MS with IFN -1b or glatiramer acetate by monthly brain MRI in the BECOME study
- (2009) D. Cadavid et al. NEUROLOGY
- MRI ASANOUTCOMEIN MULTIPLE SCLEROSIS CLINICAL TRIALS
- (2009) M. P. Sormani et al. NEUROLOGY
- Promoting oligodendrogenesis and myelin repair using the multiple sclerosis medication glatiramer acetate
- (2009) V. Skihar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Glatiramer acetate versus interferon beta-1a for subcutaneous administration: Comparison of outcomes among multiple sclerosis patients
- (2008) Jane Castelli-Haley et al. ADVANCES IN THERAPY
- Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial
- (2008) Daniel D Mikol et al. LANCET NEUROLOGY
- Demyelination arrest and remyelination induced by glatiramer acetate treatment of experimental autoimmune encephalomyelitis
- (2008) R. Aharoni et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now